KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Leases (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Leases for 6 consecutive years, with $78.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Leases rose 1785.93% year-over-year to $78.8 million, compared with a TTM value of $78.8 million through Sep 2025, up 1785.93%, and an annual FY2024 reading of $92.1 million, up 1946.95% over the prior year.
  • Leases was $78.8 million for Q3 2025 at Aurinia Pharmaceuticals, up from $3.8 million in the prior quarter.
  • Across five years, Leases topped out at $117.4 million in Q2 2023 and bottomed at $3.8 million in Q2 2025.
  • Average Leases over 5 years is $35.6 million, with a median of $5.5 million recorded in 2021.
  • The sharpest move saw Leases soared 2212.03% in 2023, then crashed 96.2% in 2025.
  • Year by year, Leases stood at $5.4 million in 2021, then fell by 8.14% to $4.9 million in 2022, then dropped by 9.04% to $4.5 million in 2023, then surged by 1946.95% to $92.1 million in 2024, then fell by 14.4% to $78.8 million in 2025.
  • Business Quant data shows Leases for AUPH at $78.8 million in Q3 2025, $3.8 million in Q2 2025, and $87.6 million in Q1 2025.